News
TLPPF
11.17
+1.55%
0.17
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 3h ago
Analysts Conflicted on These Healthcare Names: Pyxis Oncology (PYXS) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 5h ago
Weekly Report: what happened at TLPPF last week (0622-0626)?
Weekly Report · 1d ago
Citigroup Entities Exit Substantial Holder Status in Telix Pharmaceuticals
TipRanks · 06/23 07:44
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
Barchart · 06/22 16:40
Weekly Report: what happened at TLPPF last week (0615-0619)?
Weekly Report · 06/22 09:35
Telix Director David Gill Increases Stake With Nasdaq ADS Purchase
TipRanks · 06/16 22:59
Weekly Report: what happened at TLPPF last week (0608-0612)?
Weekly Report · 06/15 09:35
Weekly Report: what happened at TLPPF last week (0601-0605)?
Weekly Report · 06/08 09:33
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
Barchart · 06/01 16:00
Weekly Report: what happened at TLPPF last week (0525-0529)?
Weekly Report · 06/01 09:35
Telix Issues New Tranche of Unquoted Equity Under Employee Incentive Schemes
TipRanks · 06/01 05:38
Telix boosts CEO equity incentives with new long-term rights grant
TipRanks · 06/01 05:37
Telix Grants Share Appreciation Rights to Director Marie McDonald
TipRanks · 06/01 05:27
Telix Grants Share Appreciation Rights to Director Jellison After AGM Approval
TipRanks · 06/01 05:27
Analyst Reiterates Buy on Telix Pharmaceuticals, Sees 38–42% Upside with Unchanged $22.4 Price Target
TipRanks · 05/26 00:45
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 05/25 23:40
Canaccord Genuity Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)
TipRanks · 05/25 23:40
Weekly Report: what happened at TLPPF last week (0518-0522)?
Weekly Report · 05/25 09:37
Telix Shareholders Back All Resolutions at Annual General Meeting
TipRanks · 05/21 14:45
More
Webull provides a variety of real-time TLPPF stock news. You can receive the latest news about Telix Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About TLPPF
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.